Search research articles
Contact Us
Filters
Showing results (501-510 of 518) with videos related to
Page
of 52
Sort By:
American Heart Journal
|
November 25, 2010
Incidence and natural history of coronary artery aneurysm developing after drug-eluting stent implantation
Chul-Min Ahn, Bum-Kee Hong, Jong-Youn Kim, et al.
Nature
|
April 21, 2022
Multi-qubit entanglement and algorithms on a neutral-atom quantum computer
T M Graham, Y Song, J Scott, et al.
American Journal of Human Genetics
|
December 31, 2005
Functional variant in a bitter-taste receptor (hTAS2R16) influences risk of alcohol dependence
Anthony L Hinrichs, Jen C Wang, Bernd Bufe, et al.
Nature Medicine
|
June 17, 2022
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial
Kevin A Strauss, Michelle A Farrar, Francesco Muntoni, et al.
Nature Medicine
|
June 17, 2022
Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial
Kevin A Strauss, Michelle A Farrar, Francesco Muntoni, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
April 5, 2023
Recommendations on the use of azole antifungals in hematology-oncology patients
J R Azanza, J Mensa, J Barberán, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 13, 2016
Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State
Melissa P Wasserstein, Mary Andriola, Georgianne Arnold, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
January 23, 2016
Newborn screening for Krabbe disease in New York State: the first eight years' experience
Joseph J Orsini, Denise M Kay, Carlos A Saavedra-Matiz, et al.
The Lancet. Neurology
|
March 20, 2021
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
John W Day, Richard S Finkel, Claudia A Chiriboga, et al.
Pediatrics
|
December 26, 2012
Initiation and use of propranolol for infantile hemangioma: report of a consensus conference
Beth A Drolet, Peter C Frommelt, Sarah L Chamlin, et al.
Page
of 52
Search research articles
Search
Showing results (501-510 of 518) with videos related to
Sort By:
Page
of 52
American Heart Journal
|
November 25, 2010
Incidence and natural history of coronary artery aneurysm developing after drug-eluting stent implantation
Chul-Min Ahn, Bum-Kee Hong, Jong-Youn Kim, et al.
Nature
|
April 21, 2022
Multi-qubit entanglement and algorithms on a neutral-atom quantum computer
T M Graham, Y Song, J Scott, et al.
American Journal of Human Genetics
|
December 31, 2005
Functional variant in a bitter-taste receptor (hTAS2R16) influences risk of alcohol dependence
Anthony L Hinrichs, Jen C Wang, Bernd Bufe, et al.
Nature Medicine
|
June 17, 2022
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial
Kevin A Strauss, Michelle A Farrar, Francesco Muntoni, et al.
Nature Medicine
|
June 17, 2022
Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial
Kevin A Strauss, Michelle A Farrar, Francesco Muntoni, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
April 5, 2023
Recommendations on the use of azole antifungals in hematology-oncology patients
J R Azanza, J Mensa, J Barberán, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 13, 2016
Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State
Melissa P Wasserstein, Mary Andriola, Georgianne Arnold, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
January 23, 2016
Newborn screening for Krabbe disease in New York State: the first eight years' experience
Joseph J Orsini, Denise M Kay, Carlos A Saavedra-Matiz, et al.
The Lancet. Neurology
|
March 20, 2021
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
John W Day, Richard S Finkel, Claudia A Chiriboga, et al.
Pediatrics
|
December 26, 2012
Initiation and use of propranolol for infantile hemangioma: report of a consensus conference
Beth A Drolet, Peter C Frommelt, Sarah L Chamlin, et al.
Page
of 52